Nitish Kumar Reddy Shines in England Test
The study's findings suggest that the medication, called lisinopril, may be helping to slow down the progression of Alzheimer's disease by reducing inflammation in the brain and improving blood flow, and its potential role in preventing or slowing down the disease is a significant development in the field of medical research.
England's decision to bat first in the third Test against India at Lord's proved challenging, with Nitish Reddy taking 2-14 in his first over, including the wicket of Zak Crawley, as England struggled to 83/2 at lunch.
The pitch, with some uneven bounce, tested the openers, with genuine edges falling short and false shots increasing. Akash Deep and Jasprit Bumrah found movement and bounce, but struggled to claim wickets. However, Nitish Reddy's impressive start helped India gain an upper hand in the match.
Meanwhile, in a separate development, a new study published in the journal Nature Medicine has found that a common blood pressure medication can slow down the progression of Alzheimer's disease. The study, conducted by researchers at the University of Oxford, involved over 1,500 patients with mild cognitive impairment or dementia.
As the Test match continues, England will look to build on their slow start, while India will aim to capitalize on their strong beginning. The study on Alzheimer's disease, on the other hand, provides new hope for patients and researchers, and its findings are likely to spark further investigation into the potential benefits of the medication.